Correlation Between Viatris and Shuttle Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Viatris and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Shuttle Pharmaceuticals.

Diversification Opportunities for Viatris and Shuttle Pharmaceuticals

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viatris and Shuttle is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Viatris i.e., Viatris and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Viatris and Shuttle Pharmaceuticals

Given the investment horizon of 90 days Viatris is expected to generate 0.34 times more return on investment than Shuttle Pharmaceuticals. However, Viatris is 2.97 times less risky than Shuttle Pharmaceuticals. It trades about 0.2 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  1,176  in Viatris on August 28, 2024 and sell it today you would earn a total of  160.00  from holding Viatris or generate 13.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Shuttle Pharmaceuticals

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Viatris and Shuttle Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Shuttle Pharmaceuticals

The main advantage of trading using opposite Viatris and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.
The idea behind Viatris and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios